Researchers use pioneering stem cell techniques to better understand causes of ...
New research from the Advanced Gene and Cell Therapy Lab at Royal Holloway, University of London has used pioneering stem cell techniques to better understand why certain cells are more at risk of degenerating in Spinal Muscular Atrophy than others.
News-Medical.net - Wed, 01 Jul 2015 03:41

West Haven girl, 4, with spinal muscular atrophy defying odds
Eva, now in her second year of preschool at Seth Haley School, was born with the severest form of spinal muscular atrophy, a disease that usually kills children by age 2. Melissa Kelly said parents of children born with SMA are told by doctors, “Take ...
New Haven Register - Mon, 08 Jun 2015 16:03



Isis Rises on Trial Data for Babies With Spinal Muscular Atrophy
Isis Pharmaceuticals Inc. rose after reporting encouraging results in a small trial aimed at helping babies with a rare spinal disease. Most of the babies with spinal muscular atrophy who took the treatment, known as ISIS-SMN-RX, have lived longer ...
Bloomberg - Thu, 11 Jun 2015 09:18

ISIS Pharmaceuticals (ISIS) Stock Rallying on Positive Data for Infants With ...
TheStreet.com - Thu, 11 Jun 2015 11:00

Isis Pharmaceuticals Reports Data from ISIS-SMN Rx Phase 2 Study in Infants ...
PR Newswire (press release) - Thu, 11 Jun 2015 04:07

Infants with rare cases of SMA get stronger, live longer on Isis drug
FierceBiotech - Thu, 11 Jun 2015 04:31

Isis Pharmaceuticals to Host Webcast to Discuss Data From ISIS-SMN Rx Phase ...
MarketWatch - Wed, 10 Jun 2015 14:31

Company Update (NASDAQ:ISIS): Isis Pharmaceuticals, Inc. Reports Data from ...
Smarter Analyst - Thu, 11 Jun 2015 04:03

Isis Reports Solid Phase 2 SMA Data
Investopedia (registration) - Thu, 11 Jun 2015 14:56



Event to raise money for families with spinal muscular atrophy
SHADE — A shindig will be held at the Shade Winery on Saturday to raise money for families dealing with spinal muscular atrophy. The Adyn's Dream Summer Fundraiser will be held from 4-8 p.m. on Saturday and will feature Thai food from Rickshaw Thai, ...
Athens Messenger (registration) - Thu, 25 Jun 2015 05:32



IndyCar driver Graham Rahal fuels race to beat spinal muscular atrophy
Tori Lacey's dream of riding in an IndyCar is second only to finding a treatment for her spinal muscular atrophy. This weekend, the 18-year-old Whitby girl teamed up with driver Graham Rahal during the Honda Indy Toronto race to raise awareness about ...
Toronto Sun - Sat, 13 Jun 2015 15:41



Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data
Isis Pharmaceuticals, Inc. (ISIS - Analyst Report) announced an encouraging update from an ongoing open-label extension (OLE) study in children suffering from type II or type III spinal muscular atrophy (SMA), who have completed an open-label, phase II ...
Zacks.com - Tue, 23 Jun 2015 11:45

Isis Pharma (ISIS) Update on ISIS-SMNRx Phase 2 in SMA
StreetInsider.com - Mon, 22 Jun 2015 04:06

Isis Pharmaceuticals Reports Data from ISIS-SMN Rx in Children with Spinal ...
CNNMoney - Mon, 22 Jun 2015 04:03

Needham Boosts Price Target on ISIS Pharmaceuticals, Inc.
Smarter Analyst - Tue, 23 Jun 2015 05:45



Early Years: 4-year-old living with Spinal Muscular Atrophy
ever heard of before, but it's the leading genetic cause of death in infants and toddlers. spinal muscular atrophy, or s-m-a is commonly known as the infant version of a-l-s. an elliston girl has already beaten the odds, just by living past age two. in ...
WDBJ7 - Thu, 18 Jun 2015 03:41



AveXis gains EU Orphan Drug designation for gene therapy treatment in spinal ...
ChariSMA is currently in a fully-enrolled Phase 1 clinical trial for the treatment of spinal muscular atrophy. Infants with spinal muscular atrophy are born with a mutated or malfunctioning gene on the 5th chromosome, reducing production of a key ...
European Pharmaceutical Review - Wed, 24 Jun 2015 05:33

Explore the spinal muscular atrophy pipeline market review for 2015
WhaTech - Wed, 24 Jun 2015 05:51

AveXis' gene therapy treatment for spinal muscular atrophy gets EMA orphan ...
Pharmaceutical Business Review - Wed, 24 Jun 2015 04:03


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014